SIRT1 and pancreatic neoplasm: Combined therapy of GEM with inhibition of SIRT1, improve efficacy and survival time in a pancreatic cancer xenogeneic mice model, compared with single inhibition of SIRT1, or single GEM therapy (179), probably due to the implication of SIRT1 in chemo-sensitivity of pancreatic cancer cells (180).